These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30936513)

  • 1. Top drugs and companies by sales in 2018.
    Urquhart L
    Nat Rev Drug Discov; 2019 Mar; ():. PubMed ID: 30936513
    [No Abstract]   [Full Text] [Related]  

  • 2. The development of a method for the global health community to assess the proportion of food and beverage companies' sales that are derived from unhealthy foods.
    Bandy L; Jewell J; Luick M; Rayner M; Li Y; Shats K; Jebb S; Chang S; Dunford E
    Global Health; 2023 Dec; 19(1):94. PubMed ID: 38041091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the healthiness of UK food companies' product portfolios using food sales and nutrient composition data.
    Bandy LK; Hollowell S; Harrington R; Scarborough P; Jebb S; Rayner M
    PLoS One; 2021; 16(8):e0254833. PubMed ID: 34347807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Sales Income and Research and Development Costs for FDA-Approved Cancer Drugs Sold by Originator Drug Companies.
    Tay-Teo K; Ilbawi A; Hill SR
    JAMA Netw Open; 2019 Jan; 2(1):e186875. PubMed ID: 30644967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Top 200 Drugs by Worldwide Sales 2016.
    Sedelmeier G; Sedelmeier J
    Chimia (Aarau); 2017 Oct; 71(10):730. PubMed ID: 29070418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Analysis Between the Top-Selling Drugs in the Japanese Pharmaceutical Market and Those in the United States, the United Kingdom, France, and Germany.
    Shibata S; Uemura R; Suzuki T
    Ther Innov Regul Sci; 2016 Mar; 50(2):221-227. PubMed ID: 30227003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Top companies and drugs by sales in 2020.
    Urquhart L
    Nat Rev Drug Discov; 2021 Apr; 20(4):253. PubMed ID: 33727694
    [No Abstract]   [Full Text] [Related]  

  • 8. Top companies and drugs by sales in 2022.
    Urquhart L
    Nat Rev Drug Discov; 2023 Apr; 22(4):260. PubMed ID: 36882626
    [No Abstract]   [Full Text] [Related]  

  • 9. Top companies and drugs by sales in 2021.
    Urquhart L
    Nat Rev Drug Discov; 2022 Apr; 21(4):251. PubMed ID: 35277680
    [No Abstract]   [Full Text] [Related]  

  • 10. Top companies and drugs by sales in 2019.
    Urquhart L
    Nat Rev Drug Discov; 2020 Apr; 19(4):228. PubMed ID: 32203287
    [No Abstract]   [Full Text] [Related]  

  • 11. The sugar content of foods in the UK by category and company: A repeated cross-sectional study, 2015-2018.
    Bandy LK; Scarborough P; Harrington RA; Rayner M; Jebb SA
    PLoS Med; 2021 May; 18(5):e1003647. PubMed ID: 34003863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical company spending on research and development and promotion in Canada, 2013-2016: a cohort analysis.
    Lexchin J
    J Pharm Policy Pract; 2018; 11():5. PubMed ID: 29564139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare IS industry top 100. HBOC tops out 100.
    Elliott J
    Healthc Inform; 1997 Jun; 14(6):SS6-26. PubMed ID: 10168121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the Accuracy of Sales Forecasts Submitted by Pharmaceutical Companies Applying for Reimbursement in Austria.
    Kossmeier M; Themanns M; Hatapoglu L; Kogler B; Keuerleber S; Lichtenecker J; Sauermann R; Bucsics A; Freissmuth M; Zebedin-Brandl E
    Front Pharmacol; 2021; 12():726758. PubMed ID: 34483937
    [No Abstract]   [Full Text] [Related]  

  • 15. Market watch: Top drugs and companies by sales in 2017.
    Urquhart L
    Nat Rev Drug Discov; 2018 Mar; 17(4):232. PubMed ID: 29588516
    [No Abstract]   [Full Text] [Related]  

  • 16. The distribution of sales revenues from pharmaceutical innovation.
    Grabowski HG; Vernon J
    Pharmacoeconomics; 2000; 18 Suppl 1():21-32. PubMed ID: 11151306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of drug safety warnings on drug sales and share prices.
    Białkowski J; Clark J
    Health Econ; 2022 Jan; 31(1):174-196. PubMed ID: 34697859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Data on the correlations among brand value, market capitalization, and consolidated overseas sales ratios of Japanese companies.
    Matsumura H; Ueda T; Sagane Y
    Data Brief; 2019 Apr; 23():103808. PubMed ID: 31372453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing the difference between forecasted and actual drug sales volumes under the price-volume agreement in South Korea.
    Park SY; Han E; Kim J; Lee EK
    Health Policy; 2016 Aug; 120(8):867-74. PubMed ID: 27346072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Match your sales force structure to your business life cycle.
    Zoltners AA; Sinha P; Lorimer SE
    Harv Bus Rev; 2006; 84(7-8):80-9, 188. PubMed ID: 16846191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.